“Fatigue can be very difficult to fix — but having said that, one of the things we do when we're assessing folks with blood cancer is try to see if there are, in fact, reversible causes of fatigue.”

Dr. Matt Kalaycio shared this important insight during MyLymphomaTeam’s latest Q&A session, when members of the lymphoma community had a chance to learn more about managing and treating blood cancers.

Dr. Kalaycio joined MyLymphomaTeam’s Heather Lapidus Glassner to answer questions on how to manage fatigue, whether cardiac conditions can occur alongside blood cancers, and how someone would know whether they’re a candidate for a stem cell transplant.

Check out the video for a few more topics Dr. Kalaycio discussed during the Q&A session:

• Whether people with blood cancer should get vaccinated against COVID-19
• How to handle mental health symptoms when living with blood cancer
• Tips for talking to your oncologist via telehealth

Watch the video to see the entire one-hour event, and register to be notified about upcoming Q&A sessions on MyLymphomaTeam.

Sign Up Today

Disclaimer: The information, including but not limited to, information from presenters, text, graphics, images, and other material shared during this event is for informational purposes only. The information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you heard during this event.

Speakers:

Dr. Matt Kalaycio is a board-certified hematologist and a professor in the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. Dr. Kalaycio sits on the board of directors for the National Comprehensive Cancer Network (NCCN). His clinical interests include leukemia and hematopoietic cell transplantation, and he has published more than 200 research articles in scientific journals. Dr. Kalaycio is a former chairman of the department of hematology and medical oncology at the Taussig Cancer Institute at Cleveland Clinic, and he previously served as editor-in-chief of Hematology News. Dr. Kalaycio is a fellow of the American College of Physicians.

Heather Lapidus Glassner has over two decades of experience in market research. She has been with MyHealthTeam for six years, conducting social listening and quantitative survey research. Her focus is to raise awareness of life with chronic conditions, including leukemia, multiple sclerosis, lupus, Parkinson’s disease, COPD, Crohn’s disease and ulcerative colitis, migraine, and psoriasis. Heather's work has been presented at the Consortium of Multiple Sclerosis Centers and the International Congress on Systemic Lupus Erythematosus.